A Protease-Activated Pathway Underlying Th Cell Type 2 Activation and Allergic Lung Disease
- 15 November 2002
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 169 (10), 5904-5911
- https://doi.org/10.4049/jimmunol.169.10.5904
Abstract
The respiratory allergens that induce experimental Th cell type 2-dependent allergic lung inflammation may be grouped into two functional classes. One class of allergens, in this study termed type I, requires priming with adjuvants remote from the lung to overcome airway tolerogenic mechanisms that ordinarily preclude allergic responses to inhaled Ags. In contrast, the other, or type II, allergen class requires neither remote priming nor additional adjuvants to overcome airway tolerance and elicit robust allergic lung disease. In this study, we show in an experimental model that diverse type II allergens share in common proteolytic activity that is both necessary and sufficient for overcoming airway tolerance and induction of pulmonary allergic disease. Inactivated protease and protease-free Ag fragments showed no allergenic potency, demonstrating that only active protease acting on endogenous substrates was essential. Furthermore, induction of airway tolerance could be aborted and allergic lung disease established by simply adding purified protease to a type I allergen. Thus, exogenous proteases are common to type II allergens and may be generally required to overcome the innate resistance of the airway to Th cell type 2 activation and allergic inflammation, raising concern for their potential contribution to diseases such as asthma.Keywords
This publication has 68 references indexed in Scilit:
- Human T cell subset commitment determined by the intrinsic property of antigen: the proteolytic activity of the major mite allergen Der p 1 conditions T cells to produce more IL-4 and less IFN-γEuropean Journal of Immunology, 2001
- Degradation of bovine complement C3 by trichomonad extracellular proteinaseVeterinary Immunology and Immunopathology, 2001
- The Cysteine Protease Activity of the Major Dust Mite Allergen Der P 1 Selectively Enhances the Immunoglobulin E Antibody ResponseThe Journal of Experimental Medicine, 1999
- An airbone mold-derived product, β-1,3-D-glucan, potentiates airway allergic responsesEuropean Journal of Immunology, 1999
- PDB2MultiGIF: A Web Tool to Create Animated Images of MoleculesJournal of Molecular Modeling, 1998
- Aerosol-induced Immunoglobulin (Ig)-E Unresponsiveness to Ovalbumin Does Not Require CD8+ or T Cell Receptor (TCR)-γ/δ+ T Cells or Interferon (IFN)-γ in a Murine Model of Allergen SensitizationThe Journal of Experimental Medicine, 1998
- Proteolytic Cleavage of CD25, the α Subunit of the Human T Cell Interleukin 2 Receptor, by Der p 1, a Major Mite Allergen with Cysteine Protease ActivityThe Journal of Experimental Medicine, 1998
- Proteolytic detergent enzymes enhance the allergic antibody responses of guinea pigs to nonproteolytic detergent enzymes in a mixture: Implications for occupational exposure☆☆☆★★★Journal of Allergy and Clinical Immunology, 1997
- Respiratory Allergenicity of Detergent Enzymes in the Guinea Pig Intratracheal Test: Association with Sensitization of Occupationally Exposed IndividualsFundamental and Applied Toxicology, 1997
- Immunologic significance of a collagen-derived culture filtrate containing proteolytic activity in Aspergillus-related diseasesJournal of Allergy and Clinical Immunology, 1994